tetano
Editor, Senior Moderator
Chin Med J (Engl). 2020 Apr 1. doi: 10.1097/CM9.0000000000000839. [Epub ahead of print]
Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis.
Chen JY[SUP]1[/SUP], Qiao K[SUP]2[/SUP], Liu F[SUP]1[/SUP], Wu B[SUP]1[/SUP], Xu X[SUP]3[/SUP], Jiao GQ[SUP]4[/SUP], Lu RG[SUP]1[/SUP], Li HX[SUP]1[/SUP], Zhao J[SUP]1[/SUP], Huang J[SUP]1[/SUP], Yang Y[SUP]5[/SUP], Lu XJ[SUP]6[/SUP], Li JS[SUP]7[/SUP], Jiang SY[SUP]8[/SUP], Wang DP[SUP]8[/SUP], Hu CX[SUP]9[/SUP], Wang GL[SUP]9[/SUP], Huang DX[SUP]9[/SUP], Jiao GH[SUP]1[/SUP], Wei D[SUP]1[/SUP], Ye SG[SUP]1[/SUP], Huang JA[SUP]10[/SUP], Zhou L[SUP]1[/SUP], Zhang XQ[SUP]1[/SUP], He JX[SUP]3[/SUP].
Author information
Abstract
BACKGROUND:
Critical patients with the 2019 coronavirus disease (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.
METHODS:
From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of >1 month and extremely high sequential organ failure assessment (SOFA) scores.
RESULTS:
Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.
CONCLUSIONS:
Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained.
PMID:32251003DOI:10.1097/CM9.0000000000000839
Lung transplantation as therapeutic option in acute respiratory distress syndrome for COVID-19-related pulmonary fibrosis.
Chen JY[SUP]1[/SUP], Qiao K[SUP]2[/SUP], Liu F[SUP]1[/SUP], Wu B[SUP]1[/SUP], Xu X[SUP]3[/SUP], Jiao GQ[SUP]4[/SUP], Lu RG[SUP]1[/SUP], Li HX[SUP]1[/SUP], Zhao J[SUP]1[/SUP], Huang J[SUP]1[/SUP], Yang Y[SUP]5[/SUP], Lu XJ[SUP]6[/SUP], Li JS[SUP]7[/SUP], Jiang SY[SUP]8[/SUP], Wang DP[SUP]8[/SUP], Hu CX[SUP]9[/SUP], Wang GL[SUP]9[/SUP], Huang DX[SUP]9[/SUP], Jiao GH[SUP]1[/SUP], Wei D[SUP]1[/SUP], Ye SG[SUP]1[/SUP], Huang JA[SUP]10[/SUP], Zhou L[SUP]1[/SUP], Zhang XQ[SUP]1[/SUP], He JX[SUP]3[/SUP].
Author information
Abstract
BACKGROUND:
Critical patients with the 2019 coronavirus disease (COVID-19), even those whose nucleic acid test results had turned negative and those receiving maximal medical support, have been noted to progress to irreversible fatal respiratory failure. Lung transplantation (LT) as the sole therapy for end-stage pulmonary fibrosis related to acute respiratory distress syndrome has been considered as the ultimate rescue therapy for these patients.
METHODS:
From February 10 to March 10, 2020, three male patients were urgently assessed and listed for transplantation. After conducting a full ethical review and after obtaining assent from the family of the patients, we performed three LT procedures for COVID-19 patients with illness durations of >1 month and extremely high sequential organ failure assessment (SOFA) scores.
RESULTS:
Two of the three recipients survived post-LT and started participating in a rehabilitation program. Pearls of the LT team collaboration and perioperative logistics were summarized and continually improved. The pathological results of the explanted lungs were concordant with the critical clinical manifestation, and provided insight towards better understanding of the disease. Government health affair systems, virology detection tools, and modern communication technology all play key roles towards the survival of the patients and their rehabilitation.
CONCLUSIONS:
Lung transplantation can be performed in end-stage patients with respiratory failure due to COVID-19-related pulmonary fibrosis. If confirmed positive-turned-negative virology status without organ dysfunction, LT provided the final option for these patients to avoid certain death, with proper protection of transplant surgeons and medical staffs. By ensuring instant seamless care for both patients and medical teams, the goal of reducing the mortality rate and salvaging the lives of patients with COVID-19 can be attained.
PMID:32251003DOI:10.1097/CM9.0000000000000839